Cargando…

Metabolic disorders during pregnancy and postpartum cardiometabolic risk

Hormonal changes during pregnancy can trigger gestational diabetes (GDM), which is constantly increasing. Its main characteristic is pronounced insulin resistance, but it appears to be a multifactorial process involving several metabolic factors; taken together, the latter leads to silent or clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patti, Angelo Maria, Pafili, Kalliopi, Papanas, Nikolaos, Rizzo, Manfredi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970277/ https://www.ncbi.nlm.nih.gov/pubmed/29712720 http://dx.doi.org/10.1530/EC-18-0130

Ejemplares similares

Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Pafili, Kalliopi, et al.
Publicado: (2016)

Skin AGEs and diabetic neuropathy
por: Papachristou, Stella, et al.
Publicado: (2021)

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2022)

Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review
por: Ardeleanu, Valeriu, et al.
Publicado: (2020)

The sugar-free paradox: cardiometabolic consequences of erythritol
por: Pafili, Kalliopi, et al.
Publicado: (2023)

Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
por: Pafili, Kalliopi, et al.
Publicado: (2020)

Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus
por: Chatzikosma, Georgia, et al.
Publicado: (2016)

Effect of gestational diabetes and hypertensive disorders of pregnancy on postpartum cardiometabolic risk
por: Li, Ling-Jun, et al.
Publicado: (2018)

Skin Advanced Glycation End Products among Subjects with Type 2 Diabetes Mellitus with or without Distal Sensorimotor Polyneuropathy
por: Papachristou, Stella, et al.
Publicado: (2021)

The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
por: Papanas, Nikolaos, et al.
Publicado: (2019)

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
por: Nikolic, Dragana, et al.
Publicado: (2022)

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues
por: Rizvi, Ali A., et al.
Publicado: (2021)

Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)

New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications?
por: Popovic, Djordje S., et al.
Publicado: (2021)

Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment
por: Vekic, Jelena, et al.
Publicado: (2022)

New Trends in Antioxidant Compounds: A Precise Nutraceutical in Cardiometabolic Disorders
por: Caliceti, Cristiana, et al.
Publicado: (2019)

Rethinking gestational diabetes: hyperglycemia or a cluster of cardiometabolic abnormalities manifested during pregnancy?
por: Schmidt, Maria Inês
Publicado: (2022)

Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective
por: Fras, Zlatko, et al.
Publicado: (2021)

Molecular Endocrinology and Metabolism in 2021: What’s New
por: Rizzo, Manfredi
Publicado: (2021)

Diabetic Neuropathy Collection: Progress in Diagnosis and Screening
por: Papanas, Nikolaos
Publicado: (2020)

Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2023)

Oxidative Stress and Cardiometabolic Disorders
por: Akhigbe, Roland E., et al.
Publicado: (2021)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum
por: Grieger, Jessica A., et al.
Publicado: (2021)

Role of Natural Compounds in Oxidative Stress and Inflammation Linked to Cardiometabolic Disorders: From Biochemical Aspects to Clinical Evidences
por: Caliceti, Cristiana, et al.
Publicado: (2018)

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel
por: Al Mahmeed, Wael, et al.
Publicado: (2021)

Mental disorders during pregnancy and postpartum period
por: Kammoun, I., et al.
Publicado: (2021)

Metabolic liver disease in diabetes – From mechanisms to clinical trials
por: Dewidar, Bedair, et al.
Publicado: (2020)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
por: Papachristou, Stella, et al.
Publicado: (2021)

Emergence of cardiometabolic risk in Bangladesh
por: Gupta, Rajeev
Publicado: (2016)

Hypertension and Cardiometabolic Risk Factors
por: Neves, Mario Fritsch, et al.
Publicado: (2013)

Stratification of the risk of bipolar disorder recurrences in pregnancy and postpartum
por: Di Florio, Arianna, et al.
Publicado: (2018)

Sleep-disordered Breathing and Insomnia as Cardiometabolic Risk Factors among U.S. Hispanics/Latinx(s)
por: Ghani, Sadia B., et al.
Publicado: (2021)

Diet Quality, Cardiometabolic Risk and Diabetes
por: Della Pepa, Giuseppe
Publicado: (2023)

PPAR in Cardiovascular Disorders
por: Orekhov, Alexander N., et al.
Publicado: (2016)

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
por: Pafili, Kalliopi, et al.
Publicado: (2020)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021)

A Qualitative Study of Perceptions, Strengths, and Opportunities in Cardiometabolic Risk Management During Pregnancy and Postpartum in a Georgia Safety-Net Hospital, 2021
por: Stanhope, Kaitlyn K., et al.
Publicado: (2022)

Can Diagnostic Specificity and Phenotyping Aid in Evaluating Cardiometabolic Risk of Maternal Sleep-disordered Breathing?
por: Sharkey, Katherine M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tebbvrh0fuk5u4ievb28mc82ae